Pfizer posts surprise 4th quarter profit, but key products miss on sales
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday,...
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday,...
By Bhanvi Satija and Michael Erman (Reuters) – Pfizer on Tuesday urged investors to focus...
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) – Americans have started rolling up...
By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the updated COVID-19...
By Brendan Pierson (Reuters) – A Louisiana judge’s order sharply limiting U.S. officials’ contacts with...
(Reuters) – The U.S. government said on Tuesday it had awarded $1.4 billion for the...
A look at the day ahead in U.S. and global markets from Mike Dolan There’s...
(Reuters) – Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine...
By Michael Erman (Reuters) -Gilead Sciences on Thursday reported lower second-quarter profit as costs from...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday expressed optimism for...